All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe
Advertisement

Changing Trends in Laboratory Compliance

November 11, 2012
By Angie Drakulich
Article

Laboratory best practices for meeting regulatory and compendial requirements are changing. FDA’s emerging expectations on data integrity.

Laboratory best practices for meeting regulatory and compendial requirements are changing. FDA’s emerging expectations on data integrity, operational qualification report generation, along with the ISPE GAMP Good Practice Guide for Validation of Computerized Systems have provided the industry with new ways to approach laboratory compliance. In addition, the status of USP Informational Chapter <1058> on analytical instrument qualification is being discussed across the industry and the pharmacopeial body. A stimulus paper is being written on this chapter, offering some revision proposals.

Paul Smith, EMEA and India Compliance Program Manager at Agilent, spoke about these issues and offered some best practices for moving forward in an educational webcast. You can watch the webcast for free on demand here.

Recent Videos
Related Content

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Congress Leaves Town with Major Drug-Related Bills on Hold

Jill Wechsler
July 28th 2023
Article

Pandemic, PBM, and other policies on hold during the summer recess.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - Artur - stock.adobe.com

Large Clinical Trial Supports Alzheimer Drug Full Approval

Jill Wechsler
July 11th 2023
Article

FDA's approval of Leqembi paves the way for wider coverage of the drug by Medicare and establishes a process for further clinical testing and evaluation of treatments for this widespread, debilitating condition


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - Artur - stock.adobe.com

Long-Admired PEPFAR Program Caught in Abortion Debate

Jill Wechsler
June 16th 2023
Article

There is concern that debates will delay the five-year reauthorization of PEPFAR under review by Congress.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - Artur - stock.adobe.com

Medicare Still Won’t Pay for Alzheimer’s Drugs without Confirmatory Data

Jill Wechsler
June 5th 2023
Article

Reimbursement for Alzheimer's medicines still will occur only with the completion of studies to support full FDA approval.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - Artur - stock.adobe.com

FDA Proposes Streamlined Medication Handouts

Jill Wechsler
June 5th 2023
Article

FDA has published a new system for providing basic and essential information on patient use of drugs and certain biologic products.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - Artur - stock.adobe.com

FDA Eyes Advisory Committee Reform to Enhance Credibility

Jill Wechsler
May 26th 2023
Article

Challenges to approval decisions have prompted FDA officials to reexamine of the role and composition of the agency’s many advisory committees and to explore options for change.

Related Content

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Congress Leaves Town with Major Drug-Related Bills on Hold

Jill Wechsler
July 28th 2023
Article

Pandemic, PBM, and other policies on hold during the summer recess.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - Artur - stock.adobe.com

Large Clinical Trial Supports Alzheimer Drug Full Approval

Jill Wechsler
July 11th 2023
Article

FDA's approval of Leqembi paves the way for wider coverage of the drug by Medicare and establishes a process for further clinical testing and evaluation of treatments for this widespread, debilitating condition


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - Artur - stock.adobe.com

Long-Admired PEPFAR Program Caught in Abortion Debate

Jill Wechsler
June 16th 2023
Article

There is concern that debates will delay the five-year reauthorization of PEPFAR under review by Congress.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - Artur - stock.adobe.com

Medicare Still Won’t Pay for Alzheimer’s Drugs without Confirmatory Data

Jill Wechsler
June 5th 2023
Article

Reimbursement for Alzheimer's medicines still will occur only with the completion of studies to support full FDA approval.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - Artur - stock.adobe.com

FDA Proposes Streamlined Medication Handouts

Jill Wechsler
June 5th 2023
Article

FDA has published a new system for providing basic and essential information on patient use of drugs and certain biologic products.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - Artur - stock.adobe.com

FDA Eyes Advisory Committee Reform to Enhance Credibility

Jill Wechsler
May 26th 2023
Article

Challenges to approval decisions have prompted FDA officials to reexamine of the role and composition of the agency’s many advisory committees and to explore options for change.

About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.